
Xavier Matias-Guiu Guia
Grado: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grupos
Publicaciones
-
Carrio, I; Pieri, PL; Narula, J; Prat, L; Riva, P; Pedrini, L; Pretolani, E; Caruso, G; Sarti, G; Estorch, M; Berna, L; Riambau, V; Matias-Guiu, X; Pak, C; Ditlow, C; Chen, F; Khaw, BA
Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells
Journal Of Nuclear Cardiology 5 551-557. .
-
Chico, A; Gallart, L; Mato, E; Mayoral, C; Martin-Campos, JM; Catasus, L; Rodriguez-Espinosa, J; Matias-Guiu, X; Blanco-Vaca, F; de Leiva, A
A novel germline mutation in exon 5 of the multiple endocrine neoplasia type 1 gene
Journal Of Molecular Medicine-Jmm 76 837-839. .
-
Catasus, L; Matias-Guiu, X; Machin, P; Munoz, J; Prat, J
BaX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: Evidence for a tumor progression role in endometrial carcinomas with microsatellite instability
LABORATORY INVESTIGATION 78 1439-1444. .
-
Catasus, L; Machin, P; Matias-Guiu, X; Prat, J
Microsatellite instability in endometrial carcinomas: Clinicopathologic correlations in a series of 42 cases
HUMAN PATHOLOGY 29 1160-1164. .
-
Matias-Guiu, X; Pons, C; Prat, J
Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors
HUMAN PATHOLOGY 29 840-845. .
-
Matias-Guiu, X; Prat, J
Molecular pathology of ovarian carcinomas
VIRCHOWS ARCHIV 433 103-111. .
-
Mato, E; Matias-Guiu, X; Chico, A; Webb, SM; Cabezas, R; Berna, L; De Leiva, A
Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 83 2417-2420. .
-
Matias-Guiu, X; Lerma, E; Prat, J
Current topics in pathology of gynecologic tumors - a selective review
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY 6 121-134. .
-
Albareda, M; Puig-Domingo, M; Wengrowicz, S; Soldevila, J; Matias-Guiu, X; Caballero, A; Chico, A; De Leiva, A
Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid
Thyroid 8 385-391. .
-
Matias-Guiu, X; Machin, P; Pons, C; Lagarda, E; De Leiva, A; Prat, J
Sustentacular cells occur frequently in the familial form of medullary thyroid carcinoma
JOURNAL OF PATHOLOGY 184 420-423. .
[doi:10.1002/(SICI)1096-9896(199804)184:4<420::AID-PATH1231>3.0.CO;2-R]
-
Cuatrecasas, M; Erill, N; Musulen, E; Costa, I; Matias-Guiu, X; Prat, J
K-ras mutations in nonmucinous ovarian epithelial tumors - a molecular analysis and clinicopathologic study of 144 patients
CANCER 82 1088-1095. .
[doi:10.1002/(SICI)1097-0142(19980315)82:6<1088::AID-CNCR12>3.3.CO;2-A]
-
Chivite, A; Matias-Guiu, X; Pons, C; Algaba, F; Prat, J
Inhibin a expression in adrenal neoplasms - a new immunohistochemical marker for adrenocortical tumors
APPL IMMUNOHISTO M M 6 42-49. .
Proyectos
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU